Donzinol 10mg Tablet 10s

Donzinol 10mg Tablet 10s contains donepezil and is used to treat mild to moderate Alzheimer’s disease and other forms of dementia associated with memory loss and cognitive decline. Dementia occurs due to progressive damage to brain cells, leading to difficulties with memory, thinking, behaviour, and daily functioning. Donepezil helps improve communication between nerve cells in the brain, which may temporarily improve or stabilise memory, awareness, and the ability to perform everyday activities. Donzinol 10mg Tablet 10s does not cure Alzheimer’s disease but may help slow the worsening of symptoms in some patients.

Donzinol 10mg Tablet 10s contains donepezil, a centrally acting acetylcholinesterase inhibitor used in the management of Alzheimer’s disease and related dementias. Alzheimer’s disease is characterised by reduced levels of acetylcholine, a neurotransmitter essential for memory, learning, and cognitive function.

Donepezil works by preventing the breakdown of acetylcholine in the brain, thereby increasing its availability at nerve synapses. This enhanced cholinergic activity supports communication between nerve cells and helps improve cognitive processes such as memory, attention, and reasoning.

The medicine is commonly prescribed in the early and middle stages of Alzheimer’s disease and may help patients maintain independence in daily activities for a longer period. Clinical benefits may include improved memory, better orientation, and reduced behavioural symptoms such as confusion or agitation in some individuals.

Donepezil begins to act gradually, and noticeable benefits may take several weeks to appear. Treatment response varies between individuals. The medicine is metabolised by the liver and eliminated through urine and bile, so dose adjustments may be required in patients with liver impairment. When taken consistently under medical supervision, Donzinol 10mg Tablet 10s can be a useful long-term therapy for managing cognitive symptoms of dementia.

Alzheimer’s Disease (Mild to Moderate)

Helps improve or stabilise memory, thinking ability, and daily functioning.

Dementia-Related Cognitive Decline

Used to manage cognitive symptoms such as confusion, forgetfulness, and reduced attention.

Behavioural Symptoms of Dementia

May help reduce agitation, apathy, or mood changes associated with cognitive decline.

Long-Term Symptom Management

Supports ongoing cognitive function when used consistently as prescribed.

Improves Cognitive Function

Enhances memory, attention, and learning ability in some patients.

Supports Daily Activities

May help patients maintain independence in routine tasks for longer.

Slows Symptom Progression

Can delay worsening of cognitive symptoms in mild to moderate stages.

Well-Studied Therapy

Widely used with established clinical evidence in Alzheimer’s disease.

Once-Daily Dosing

Simple dosing schedule improves adherence.

When taken as directed, Donzinol 10mg Tablet 10s is generally well tolerated. Side effects are usually mild to moderate and may lessen with continued use.

Common Side Effects

• Nausea, vomiting, or diarrhoea, especially at the start of treatment

• Loss of appetite or weight loss

• Headache or dizziness

• Insomnia or abnormal dreams

• Muscle cramps

Uncommon Side Effects

• Slow heart rate (bradycardia)

• Fainting or near-fainting episodes

• Fatigue or weakness

• Mood changes or agitation

Serious Side Effects (Require Immediate Medical Attention)

• Severe vomiting or dehydration

• Irregular or very slow heartbeat

• Seizures

• Gastrointestinal bleeding, such as black stools or blood in vomit

Donzinol 10mg Tablet 10s should be taken exactly as prescribed by the doctor. The usual starting dose is one 5 mg tablet taken once daily, preferably at bedtime. Taking the medicine at night may reduce the impact of certain side effects such as dizziness or nausea.

Swallow the tablet whole with water. It can be taken with or without food. Dose increases, if required, should only be done under medical supervision after assessing tolerance and response.

• Consistent Dosing: Take the medicine at the same time every day, preferably at bedtime, to maintain steady drug levels and reduce the likelihood of nausea or dizziness.

• Caregiver Involvement: A caregiver should supervise daily dosing and observe changes in memory, behaviour, sleep, or mood to help assess treatment response and safety.

• Monitor Weight and Appetite: Regular monitoring of body weight and food intake is important, as reduced appetite and gradual weight loss may occur during long-term use.

• Heart Rate Awareness: Symptoms such as dizziness, fainting, fatigue, or palpitations should be reported promptly, as donepezil can slow the heart rate in susceptible individuals.

• Do Not Stop Abruptly: Sudden discontinuation may lead to worsening confusion or decline in daily functioning, so dose changes should always be gradual and doctor-supervised.

• Fall Risk Precautions: Elderly patients should rise slowly from sitting or lying positions and ensure home safety measures to reduce the risk of falls.

• Regular Review: Periodic cognitive and functional assessments help determine whether continued treatment remains beneficial.

• Alcohol (Moderate): Alcohol may worsen confusion, drowsiness, dizziness, and coordination problems, increasing the risk of falls and injury.

• Large or Heavy Meals (Low): Heavy meals may aggravate nausea or stomach discomfort, especially during the initial weeks of treatment.

• Caffeine (Low): Excessive caffeine intake may worsen sleep disturbances or restlessness in some patients.

• Anticholinergic Medicines (Moderate): Drugs such as certain bladder medicines or antihistamines may counteract the cognitive benefits of donepezil.

• NSAIDs (Moderate): Combined use may increase the risk of stomach irritation or gastrointestinal bleeding.

• Beta-Blockers and Heart-Rate-Lowering Drugs (Moderate): Concurrent use may increase the risk of excessive slowing of the heart rate or fainting.

• CYP3A4 or CYP2D6 Inhibitors (Moderate): Medicines such as some antibiotics, antifungals, or antidepressants may raise donepezil levels and side effects.

• Muscle Relaxants and Anaesthetics (Moderate): Donepezil can enhance neuromuscular blockade during surgery, so healthcare providers must be informed beforehand.

• Heart Rhythm Disorders (High): Donepezil may exacerbate slow heart rate or conduction abnormalities, requiring close monitoring or avoidance in affected patients.

• Peptic Ulcer Disease or GI Bleeding (Moderate): Increased cholinergic activity can raise stomach acid secretion and increase bleeding risk.

• Seizure Disorders (Moderate): The medicine may lower seizure threshold and should be used cautiously in patients with epilepsy.

• Asthma or COPD (Moderate): Cholinergic effects may worsen bronchoconstriction and breathing symptoms in susceptible individuals.

• Liver Disease (Moderate): Impaired liver function can slow drug metabolism and increase side-effect risk, necessitating careful dose monitoring.

• Low Body Weight or Frailty (Moderate): Frail patients may experience side effects more easily and require closer observation.

If you miss a dose, take it as soon as you remember on the same day. If it is close to the time for your next dose, skip the missed one and continue with your regular schedule. Do not take two doses at the same time. If several doses are missed, consult your doctor before restarting the medicine.